Correct the model does not account for, nor could it account for cross-over affects. There are limitations but this is the best model one can make given the limited number of data points available. Since both the control and the experimental groups where modeled after the IMUC control curve dataset, I believe that likely the real trial outcome would be better than this for the whole NWBO group.